Table 1.
Model feature | FHCRC | MISCAN | UMICH |
---|---|---|---|
Implementation | simulation | simulation | analytic |
Disease states | (2 stages) × (2 grades) | (3 × 2 stages) × (3 grades) | (2 stages) × (2 grades) |
local-regional, distant stage | T0 T3 local, distant stage | local-regional, distant stage | |
low-moderate, high grade | low, moderate, high grade | low-moderate, high grade | |
Progression depends on | current PSA level | current disease state | delay time and mode of detection |
Stage progression | yes | yes | yes |
Grade progression | no | yes | yes |
PSA test sensitivity* | output of model | endogenous parameter | endogenous parameter |
Biopsy compliance† | estimated from PLCO | combined with PSA sensitivity | combined with PSA sensitivity |
Biopsy sensitivity‡ | based on literature review | combined with PSA sensitivity | combined with PSA sensitivity |
Pr(PSA positive|Disease)
Pr(Biopsy received|PSA positive, Disease)
Pr(Biopsy positive | Biopsy received, Disease)